Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
50.41
-1.43 (-2.75%)
Mar 13, 2026, 3:49 PM EDT - Market open
Maze Therapeutics Revenue
In the year 2024, Maze Therapeutics had annual revenue of $167.50M.
Revenue (ttm)
$167.50M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
125
Market Cap
2.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 167.50M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMAZE News
- 16 days ago - Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 2 months ago - Maze Therapeutics: An Innovative, Nature-Driven Platform - Seeking Alpha
- 2 months ago - Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Maze Therapeutics, Inc. (MAZE) Presents at Jefferies London Healthcare Conference 2025 Prepared Remarks Transcript - Seeking Alpha
- 4 months ago - Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights - GlobeNewsWire
- 4 months ago - Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week - GlobeNewsWire
- 4 months ago - Maze Therapeutics to Participate in Four Upcoming Investor Conferences - GlobeNewsWire